Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging

Neurobiology of Aging

Volumn 45, Issue , 2016, Pages 190-196

  van de Haar, Harm J ^a,b   Jansen, Jacobus F A ^a,b   van Osch, Matthias J P ^c   van Buchem, Mark A ^c   Muller, Majon ^c   Wong, Sau May ^a,b   Hofman, Paul A M ^a,b   Burgmans, Saartje ^a,b   Verhey, Frans R J ^a,b   Backes, Walter H ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Blood brain barrier; Cerebral hemodynamics; Dementia; Magnetic resonance imaging

Indexed keywords

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTERIAL SPIN LABELING MAGNETIC RESONANCE IMAGING; ARTICLE; ATHEROSCLEROSIS; BLOOD BRAIN BARRIER; BLOOD VOLUME; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GRAY MATTER; HEART ARRHYTHMIA; HUMAN; IMAGE ANALYSIS; INCIDENCE; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTITION COEFFICIENT; PRIORITY JOURNAL; VERY ELDERLY; WECHSLER ADULT INTELLIGENCE SCALE; BRAIN CIRCULATION; DIAGNOSTIC IMAGING; MICROVASCULATURE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD-BRAIN BARRIER; CEREBROVASCULAR CIRCULATION; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS;

EID: 84978946283     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.06.006     Document Type: Article

References (65)

1. Abbott, N.J., Patabendige, A.A.K., Dolman, D.E.M., Yusof, S.R., Begley, D.J., Structure and function of the blood-brain barrier. Neurobiol. Dis. 37 (2010), 13–25.
2. Alsop, D.C., Dai, W., Grossman, M., Detre, J.A., Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J. Alzheimer's Dis. 20 (2010), 871–880.
3. Alsop, D.C., Detre, J.A., Golay, X., Günther, M., Hendrikse, J., Hernandez-Garcia, L., Lu, H., MacIntosh, B.J., Parkes, L.M., Smits, M., van Osch, M.J.P., Wang, D.J.J., Wong, E.C., Zaharchuk, G., Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn. Reson. Med. 73 (2015), 102–116.
4. Armitage, P.A., Farrall, A.J., Carpenter, T.K., Doubal, F.N., Wardlaw, J.M., Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities. Magn. Reson. Imaging 29 (2011), 305–314.
5. Austin, B.P., Effects of hypoperfusion in Alzheimer's disease. J. Alzheimers Dis. 26 (2011), 123–133.
6. Barker, R., Ashby, E.L., Wellington, D., Barrow, V.M., Palmer, J.C., Kehoe, P.G., Esiri, M.M., Love, S., Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain 137 (2014), 1524–1532.
7. Barnes, S.R., Ng, T.S.C., Montagne, A., Law, M., Zlokovic, B.V., Jacobs, R.E., Optimal acquisition and modeling parameters for accurate assessment of low K trans blood-brain barrier permeability using dynamic contrast-enhanced MRI. Magn. Reson. Med. 75 (2016), 1967–1977.
8. Benarroch, E.E., Neurovascular unit dysfunction: a vascular component of Alzheimer disease?. Neurology 68 (2008), 1730–1732.
9. Binnewijzend, M.A., Kuijer, J.P.A., Van Der Flier, W.M., Benedictus, M.R., Möller, C.M., Pijnenburg, Y.A.L., Lemstra, A.W., Prins, N.D., Wattjes, M.P., Van Berckel, B.N.M., Scheltens, P., Barkhof, F., Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies. Eur. Radiol. 24 (2014), 2326–2333.
10. Chen, W., Song, X., Beyea, S., Arcy, R.D., Zhang, Y., Advances in perfusion magnetic resonance imaging in Alzheimer's disease. Alzheimer's Dement. 7 (2011), 185–196.
11. Cramer, S.P., Larsson, H.B.W., Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients. J. Cereb. Blood Flow Metab. 34 (2014), 1655–1665.
12. Cramer, S.P., Simonsen, H., Frederiksen, J.L., Rostrup, E., Larsson, H.B.W., Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI. Neuroimage Clin. 4 (2014), 182–189.
13. Dai, W., Lopez, O.L., Carmichael, O.T., Becker, J.T., Kuller, L.H., Gach, H.M., Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 250 (2009), 856–866.
14. De La Torre, J.C., Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 3 (2004), 184–190.
15. Drachman, D.A., The amyloid hypothesis, time to move on: amyloid is the downstream result, not cause, of Alzheimer's disease. Alzheimer's Dement 10 (2014), 372–380.
16. Dubois, B., Feldman, H.H., Jacova, C., DeKosky, S.T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P.J., Scheltens, P., Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6 (2007), 734–746.
17. Farkas, E., Luiten, P.G., Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64 (2001), 575–611.
18. Fazekas, F., Kleinert, R., Offenbacher, H., Schmidt, R., Kleinert, G., Payer, F., Radner, H., Lechner, H., Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43 (1993), 1683–1689.
19. Fischl, B., Salat, D.H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., Van Der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., Montillo, A., Makris, N., Rosen, B., Dale, A.M., Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33 (2002), 341–355.
20. Folstein, M.F., Folstein, S.E., McHugh, P.R., “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975), 189–198.
21. Haroon, H.A., Buckley, D.L., Patankar, T.A., Dow, G.R., Rutherford, S.A., Balériaux, D., Jackson, A., A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas. J. Magn. Reson. Imaging 19 (2004), 527–536.
22. Hawkins, B.T., Davis, T.P., The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57 (2005), 173–185.
23. Herscovitch, P., Raichle, M.E., What is the correct value for the brain blood partition-coefficient for water. J. Cereb. Blood Flow Metab. 5 (1985), 65–69.
24. Heye, A.K., Thrippleton, M.J., Armitage, P.A., Valdés Hernández Mdel, C., Makin, S.D., Glatz, A., Sakka, E., Wardlaw, J.M., Tracer kinetic modelling for DCE-MRI quantification of subtle blood–brain barrier permeability. Neuroimage 125 (2016), 446–455.
25. Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A., Martin, R.L., A new clinical scale for the staging of dementia. Br. J. Psychiatry 140 (1982), 566–572.
26. Iadecola, C., The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 120 (2010), 287–296.
27. Iadecola, C., The pathobiology of vascular dementia. Neuron 80 (2013), 844–866.
28. Jack, C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Petersen, R.C., Trojanowski, J.Q., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9 (2010), 119–128.
29. Janota, C., Lemere, C.A., Brito, M.A., Dissecting the contribution of vascular alterations and aging to Alzheimer's disease. Mol. Neurobiol, 2015, 10.1007/s12035-015-9319-7.
30. Jelescu, I.O., Leppert, I.R., Narayanan, S., Araújo, D., Arnold, D.L., Pike, G.B., Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions. J. Magn. Reson. Imaging 33 (2011), 1291–1300.
31. Jenkinson, M., Bannister, P., Brady, M., Smith, S.M., Improved optimisation for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17 (2002), 825–841.
32. Keaney, J., Walsh, D.M., O'Malley, T., Hudson, N., Crosbie, D.E., Loftus, T., Sheehan, F., McDaid, J., Humphries, M.M., Callanan, J.J., Brett, F.M., Farrell, M.A., Humphries, P., Campbell, M., Autoregulated paracellular clearance of amyloid-across the blood-brain barrier. Sci. Adv., 1, 2015, e1500472.
33. Kehoe, E.G., McNulty, J.P., Mullins, P.G., Bokde, A.L.W., Advances in MRI biomarkers for the diagnosis of Alzheimer's disease. Biomark. Med. 8 (2014), 1151–1169.
34. Lacalle-Aurioles, M., Mateos-Pérez, J.M., Guzmán-De-Villoria, J.A., Olazarán, J., Cruz-Orduña, I., Alemán-Gómez, Y., Martino, M.-E., Desco, M., Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease. J. Cereb. Blood Flow Metab. 34 (2014), 654–659.
35. Larsson, H.B.W., Courivaud, F., Rostrup, E., Hansen, A.E., Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T1-weighted MRI at 3 tesla. Magn. Reson. Med. 62 (2009), 1270–1281.
36. Larsson, H.B.W., Tofts, P.S., Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning—a comparison of methods. Magn. Reson. Med. 24 (1992), 174–176.
37. Lavini, C., Verhoeff, J.J.C., Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population. Magn. Reson. Imaging 28 (2010), 1420–1430.
38. Lecrux, C., Hamel, E., The neurovascular unit in brain function and disease. Acta Physiol. 203 (2011), 47–59.
39. Li, K.L., Zhu, X.P., Waterton, J., Jackson, A., Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J. Magn. Reson. Imaging 12 (2000), 347–357.
40. Lu, H., Clingman, C., Golay, X., Van Zijl, P.C.M., Determining the longitudinal relaxation time (T1) of blood at 3.0 tesla. Magn. Reson. Med. 52 (2004), 679–682.
41. Lyros, E., Bakogiannis, C., Liu, Y., Fassbender, K., Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease. Curr. Alzheimer Res. 11 (2014), 18–26.
42. Mattsson, N., Tosun, D., Insel, P.S., Simonson, A., Jack, C.R., Beckett, L.A., Donohue, M., Jagust, W., Schuff, N., Weiner, M.W., Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain 137 (2014), 1550–1561.
43. McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R., Kawas, C.H., Klunk, W.E., Koroshetz, W.J., Manly, J.J., Mayeux, R., Mohs, R.C., Morris, J.C., Rossor, M.N., Scheltens, P., Carrillo, M.C., Thies, B., Weintraub, S., Phelps, C.H., The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 7 (2011), 263–269.
44. Montagne, A., Barnes, S.R., Sweeney, M.D., Halliday, M.R., Sagare, A.P., Zhao, Z., Toga, A.W., Jacobs, R.E., Liu, C.Y., Amezcua, L., Harrington, M.G., Chui, H.C., Law, M., Zlokovic, B.V., Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85 (2015), 296–302.
45. Moroney, J.T., Bagiella, E., Desmond, D.W., Hachinski, V.C., Mölsä, P.K., Gustafson, L., Brun, A., Fischer, P., Erkinjuntti, T., Rosen, W., Paik, M.C., Tatemichi, T.K., Meta-analysis of the Hachinski ischemic score in pathologically verified dementias. Neurology 49 (1997), 1096–1105.
46. Morris, J.C., The clinical dementia rating (CDR): current version and scoring rules. Neurology 43 (1993), 2412–2414.
47. Nicolakakis, N., Hamel, E., Neurovascular function in Alzheimer's disease patients and experimental models. J. Cereb. Blood Flow Metab. 31 (2011), 1354–1370.
48. Patlak, C.S., Blasberg, R.G., Fenstermacher, J.D., Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3 (1983), 1–7.
49. Prins, N.D., Scheltens, P., White matter hyperintensities, cognitive impairment and dementia: an update. Nat. Rev. Neurol. 11 (2015), 157–165.
50. Roher, A., Debbins, J.P., Malek-Ahmadi, M., Pipe, J.G., Maze, S., Belden, C., Maarouf, C.L., Hunter, J.M., Kokjohn, T.A., Walker, D.G., Kruchowsky, J.C., Belohlavek, M., Beach, T.G., Sabbagh, M., Chen, K., Mo, H., Thiyyagura, P., Cerebral blood flow in Alzheimer's disease. Vasc. Health Risk Manag. 8 (2012), 599–611.
51. Sagare, A.P., Bell, R.D., Zlokovic, B.V., Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. Selkoe, DJ, Mandelkow, E, Holtzman, DM, (eds.) The Biology of Alzheimer's Disease, 2012, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 405–422.
52. Schabel, M.C., Parker, D.L., Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys. Med. Biol. 53 (2008), 2345–2373.
53. Scheltens, P., Leys, D., Barkhof, F., Huglo, D., Weinstein, H.C., Vermersch, P., Kuiper, M., Steinling, M., Wolters, E.C., Valk, J., Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J. Neurol. Neurosurg. Psychiatry 55 (1992), 967–972.
54. Sourbron, S., Technical aspects of MR perfusion. Eur. J. Radiol. 76 (2010), 304–313.
55. Sourbron, S.P., Buckley, D.L., Classic models for dynamic contrast-enhanced MRI. NMR Biomed. 26 (2013), 1004–1027.
56. Stanimirovic, D.B., Friedman, A., Pathophysiology of the neurovascular unit: disease cause or consequence?. J. Cereb. Blood Flow Metab. 32 (2012), 1207–1221.
57. Taheri, S., Gasparovic, C., Shah, N.J., Rosenberg, G.A., Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping. Magn. Reson. Med. 65 (2011), 1036–1042.
58. Tofts, P.S., Brix, G., Buckley, D.L., Evelhoch, J.L., Henderson, E., Knopp, M.V., Larsson, H.B.W., Lee, T.Y., Mayr, N.A., Parker, G.J.M., Port, R.E., Taylor, J., Weisskoff, R.M., Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 10 (1999), 223–232.
59. Uh, J., Lewis-Amezcua, K., Martin-Cook, K., Cheng, Y., Weiner, M., Diaz-Arrastia, R., Devous, M., Shen, D., Lu, H., Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity. Neurobiol. Aging 31 (2010), 2038–2046.
60. van de Haar, H.J., Burgmans, S., Jansen, J.F.A., van Osch, M.J.P., van Buchem, M.A., Muller, M., Hofman, P.A.M., Verhey, F.R.J., Backes, W.H., Blood-brain barrier leakage in early Alzheimer's disease. Radiology, 2016.
61. van der Elst, W., van Boxtel, M.P.J., van Breukelen, G.J.P., Jolles, J., The letter digit substitution test: normative data for 1,858 healthy participants aged 24-81 from the Maastricht Aging Study (MAAS): influence of age, education, and sex. J. Clin. Exp. Neuropsychol. 28 (2006), 998–1009.
62. Van Osch, M.J.P., Teeuwisse, W.M., Van Walderveen, M.A.A., Hendrikse, J., Kies, D.A., Van Buchem, M.A., Can arterial spin labeling detect white matter perfusion signal?. Magn. Reson. Med. 62 (2009), 165–173.
63. Wechsler, D., WAIS-III/WMS-III Technical Manual Update. third ed., 1997, Psychological Corporation, San Antonio.
64. Zlokovic, B.V., Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 28 (2005), 202–208.
65. Zlokovic, B.V., Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12 (2011), 723–738.